United States · FDA National Drug Code directory

Cyclobenzaprine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-9967_e381786e-1a5f-4d43-b7d1-3abc16c3dec3
Product NDC
68788-9967
Form
TABLET, FILM COATED
Composition / generic term
Cyclobenzaprine Hydrochloride
Labeler
Preferred Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20150501
Source listing expiry
20271231

Source-listed ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE — 7.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (68788-9967-1) · 68788-9967-1
  • 20 TABLET, FILM COATED in 1 BOTTLE (68788-9967-2) · 68788-9967-2
  • 30 TABLET, FILM COATED in 1 BOTTLE (68788-9967-3) · 68788-9967-3
  • 60 TABLET, FILM COATED in 1 BOTTLE (68788-9967-6) · 68788-9967-6
  • 8 TABLET, FILM COATED in 1 BOTTLE (68788-9967-7) · 68788-9967-7
  • 120 TABLET, FILM COATED in 1 BOTTLE (68788-9967-8) · 68788-9967-8
  • 90 TABLET, FILM COATED in 1 BOTTLE (68788-9967-9) · 68788-9967-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →